Related Experiment Video

Updated: Jun 10, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior

Francesco Pierconti1, Maurizio Martini, Francesco Pinto

  • 1Institute of Pathological Anatomy, Catholic University of Sacred Heart, Rome, Italy.

The Prostate
|August 19, 2010
PubMed
Abstract

Insights

Suppressor of cytokine signaling 3 (SOCS3) gene promoter hypermethylation is frequent in prostate cancer, leading to reduced expression and association with aggressive disease. This epigenetic silencing may drive prostate cancer development and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Chronic inflammation and tissue alterations are implicated in prostate cancer development.
  • The suppressor of cytokine signaling 3 (SOCS3) gene regulates inflammatory signaling pathways, particularly involving interleukin-6 (IL-6).
  • Alterations in SOCS3 may contribute to the complex role of IL-6 in prostate carcinogenesis.

Purpose of the Study:

  • To investigate the methylation status and mRNA expression of the SOCS3 gene in benign prostate hyperplasia (BPH) and prostate cancer.
  • To determine the correlation between SOCS3 epigenetic alterations and clinical parameters in prostate cancer patients.

Main Methods:

  • Analysis of SOCS3 promoter methylation using methylation-specific PCR and sequencing.
  • Quantification of SOCS3 mRNA expression via real-time PCR.
  • Assessment of SOCS3 protein levels through immunohistochemistry.
  • Statistical analysis of results and clinical data.

Main Results:

  • SOCS3 promoter hypermethylation was detected in 39.2% of prostate cancer specimens, but not in BPH or normal controls.
  • Methylated SOCS3 cases exhibited significantly reduced mRNA expression compared to BPH and unmethylated prostate cancer.
  • SOCS3 promoter methylation strongly correlated with higher Gleason scores and unfavorable clinical outcomes in prostate cancer.

Conclusions:

  • SOCS3 hypermethylation is a potential mechanism involved in prostate cancer pathogenesis.
  • Epigenetic silencing of SOCS3 may identify a subset of prostate tumors with aggressive behavior.
  • SOCS3 alterations represent a potential biomarker for predicting prostate cancer prognosis.

More Related Videos

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...